Assessment of chemotherapy-associated nephrotoxicity in children with cancer.
about
Early and late renal adverse effects after potentially nephrotoxic treatment for childhood cancerDose-related nephrotoxicity of carboplatin in childrenDiscovering Outliers of Potential Drug Toxicities Using a Large-scale Data-driven ApproachPhase II study of cisplatin and oral VP16 in patients with refractory or relapsed Ewing sarcoma.Inaccuracy of glomerular filtration rate estimation from height/plasma creatinine ratioDevelopment of tumor-specific caffeine-potentiated chemotherapy using a novel drug delivery system with Span 80 nano-vesicles.Renal dysfunction and elevated blood pressure in long-term childhood cancer survivorsThe influence of ifosfamide scheduling on acute nephrotoxicity in childrenRisk factors for nephrotoxicity after ifosfamide treatment in children: a UKCCSG Late Effects Group study. United Kingdom Children's Cancer Study Group.Osteomalacia as a late metabolic complication of Ifosfamide chemotherapy in young adults: illustrative cases and review of the literature.Cell death-inducing effect of novel palladium(II) and platinum(II) complexes on non-small cell lung cancer cells in vitro.The influence of age on nephrotoxicity following chemotherapy in childrenCisplatin dose rate as a risk factor for nephrotoxicity in children.Late reversibility of chronic ifosfamide-associated nephrotoxicity in a child.Evaluation of serious adverse events in patients treated with protocols including methotrexate infusions.Renal toxicity and chemotherapy in children with cancer.
P2860
Q24197545-13CF7160-E3AA-4AD8-B43A-09FA8783F52DQ28343589-395C0DB4-2B1A-434E-9E68-BE103D67BF1CQ31140868-E3212C57-49A6-43A2-A969-208F4ACD1DA8Q33404428-F6C2ACBF-2FF2-4FF8-B2CC-29E87A9CFFC7Q33624602-DEBC2681-F7A6-4FFD-AF04-9E0FEF0F1523Q35172556-67A81872-1192-490B-A91C-EDF169A38627Q36199534-21136A04-F6A0-458E-9BAD-515E433292A7Q36431761-B927C76B-05AC-40B2-B2D2-ACC8FD5EAA9AQ36641763-1B51888D-BE29-47C3-BD39-EF6BF9CEC291Q36887175-F362C200-A183-4A30-96B8-72ABBF91782CQ39496583-3928BAF2-830C-4906-98F0-E6D5CB083D88Q41111173-75B9F7DA-79FE-48D2-A8F4-4CE4283906BFQ41824829-8439E077-2C0B-4437-AFE3-669565D35286Q42552096-894E29E2-50FA-4D4C-99F1-C9CE2E9717EAQ48158784-BE99DB60-58A6-4784-A2DC-6BC2F960D34BQ48321401-C0F154AF-2776-42F9-88AA-5B6B8D3F134D
P2860
Assessment of chemotherapy-associated nephrotoxicity in children with cancer.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 1991
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Assessment of chemotherapy-associated nephrotoxicity in children with cancer.
@en
Assessment of chemotherapy-associated nephrotoxicity in children with cancer.
@nl
type
label
Assessment of chemotherapy-associated nephrotoxicity in children with cancer.
@en
Assessment of chemotherapy-associated nephrotoxicity in children with cancer.
@nl
prefLabel
Assessment of chemotherapy-associated nephrotoxicity in children with cancer.
@en
Assessment of chemotherapy-associated nephrotoxicity in children with cancer.
@nl
P2093
P2860
P356
P1476
Assessment of chemotherapy-associated nephrotoxicity in children with cancer.
@en
P2093
A D Pearson
A W Hodson
A W Skillen
M E Goldfinch
M G Coulthard
P2860
P2888
P356
10.1007/BF00689694
P577
1991-01-01T00:00:00Z